Depression genes under the microscope: new study aims to uncover clues
NCT ID NCT00998231
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how certain genes behave in people with major depression compared to healthy individuals. Researchers collected blood samples from 30 participants to measure the activity of 21 specific genes. The goal is to better understand how depression changes over time at the molecular level, which could one day lead to improved diagnosis or treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help identify biological markers for depression, potentially leading to better diagnosis or treatment targets in the future.
- What could go wrong
- This is a small, early-stage observational study with only 30 participants. It does not test a treatment, so it may not directly lead to new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE EPISODE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assistance Publique-Hôpitaux de Marseille
Marseille, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Decoding depression: sleep rhythms as biomarkers?
- Brain wave clues: could inflammation markers forecast ECT outcomes?
- Brain wave patterns and inflammation: a clue to ECT's effectiveness in older adults?
- Magnetic brain pulses aim to quiet suicidal urges
- Could a flickering light headset lift depression?
- Brain zaps at home may boost sleep and fight depression